Charles Schwab Investment Management Inc. grew its stake in shares of Novartis AG (NYSE:NVS – Get Rating) by 0.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,568,714 shares of the company’s stock after acquiring an additional 41,253 […]
Headinvest LLC decreased its holdings in Novartis AG (NYSE:NVS – Get Rating) by 1.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,769 shares of the company’s stock after selling 196 shares during the period. Headinvest LLC’s holdings in Novartis were worth $1,703,000 as of […]
Heritage Wealth Management LLC raised its position in shares of Novartis AG (NYSE:NVS – Get Rating) by 123.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,680 shares of the company’s stock after purchasing an additional 10,882 shares during the period. Heritage Wealth […]
Avalon Investment & Advisory reduced its stake in Novartis AG (NYSE:NVS – Get Rating) by 5.5% in the 4th quarter, Holdings Channel reports. The firm owned 43,544 shares of the company’s stock after selling 2,556 shares during the period. Avalon Investment & Advisory’s holdings in Novartis were worth $3,950,000 as of its most recent filing […]
CIBC Private Wealth Group LLC cut its stake in Novartis AG (NYSE:NVS – Get Rating) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 411,676 shares of the company’s stock after selling 9,262 shares during the period. CIBC Private […]